VERDE BIO HOLDINGS, INC. (APHD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue Annual

0 20K 40K 60K FY11: 6K FY12: 1.5K FY13: 689 FY14: 485 FY15: 258 FY16: 2.7K FY17: 50.3K FY18: 41.9K FY19: 0 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

Gross Profit Annual

-10K 0 10K 20K 30K FY16: 904 FY17: 28.2K FY18: 18.5K FY19: 0 FY20: 0 FY21: -1.7K FY16 FY17 FY18 FY19 FY20 FY21

Operating Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY12: -151.5K FY13: -160.8K FY14: -134.5K FY15: -233.5K FY16: -196.3K FY17: -456.1K FY18: -450.8K FY19: -37.1K FY20: -259.2K FY21: -3M FY22: -3.2M FY23: -1.6M FY13 FY15 FY17 FY19 FY21 FY23

Net Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY11: -129.4K FY12: -145.5K FY13: -120.8K FY14: -404.8K FY15: -797.9K FY16: -125.6K FY17: -2.1M FY18: -1.5M FY19: -537.1K FY20: -1.6M FY21: 0 FY22: -3.4M FY23: -1.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23

Cost of Revenue Annual

0 8K 16K 24K FY17: 22.1K FY18: 23.3K FY19: 0 FY17 FY18 FY19

Operating Cash Flow Annual

-1.2M -800K -400K 0 400K 800K 1.2M FY11: -84.3K FY12: -33.2K FY13: -3.3K FY14: -51.7K FY15: -61.6K FY16: -9.4K FY17: -265.7K FY18: -225K FY19: -16.4K FY20: -177.8K FY21: -685.2K FY22: -1.2M FY23: -872.2K FY11 FY13 FY15 FY17 FY19 FY21 FY23

Free Cash Flow Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY11: -86.1K FY12: -33.2K FY22: -4M FY23: -879.2K FY11 FY12 FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '11: -0.03 Q1 '12: -0.02 Q2 '12: -0.01 Q3 '12: -0.01 Q4 '12: -0.01 Q1 '13: -0.01 Q2 '13: -0.01 Q3 '13: -0.01 Q4 '13: -0.01 Q1 '14: -0.02 Q2 '14: -0.04 Q3 '14: -6.82 Q4 '14: -6.65 Q1 '15: -7.31 Q2 '15: -8.18 Q3 '15: -1.66 Q4 '15: -1.00 Q1 '16: -0.33 Q2 '16: 0.38 Q3 '16: 0.61 Q1 '18: -1.49 Q2 '18: -1.53 Q3 '18: -1.51 Q4 '18: -0.12 Q1 '20: -1.07 Q2 '20: -1.14 Q3 '20: -1.28 Q4 '20: -1.06 Q1 '21: -0.74 Q2 '21: -0.56 Q3 '21: -0.34 Q4 '21: -0.03 Q1 '22: 0.01 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q4 '11 Q1 '13 Q2 '14 Q3 '15 Q1 '18 Q2 '20 Q3 '21 Q4 '22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.